Drugmaker Cipla on Wednesday said it has launched a medication for managing obesity and type-2 diabetes mellitus ...

Global blockbuster fat-busting injection Mounjaro became India's top-selling medicine brand within months of its launch ...

The latest announcement is out from Cipla Ltd ( (IN:CIPLA) ).

The Mumbai-based drugmaker, in a regulatory filing, said it has the rights to distribute and promote Yurpeak, the second anti ...

Tata Steel, Adani Enterprises, SBI, Cipla are some of the stocks that will remain in focus on Thursday, 11 December 2025.

Track 10 key stocks including IndiGo, LIC, Cipla, and TCS for major news and market updates—see which companies are making ...

Stocks of Cipla Ltd., InterGlobe Aviation Ltd., Mazagon Dock Shipbuilders Ltd., Life Insurance Corp., Meesho Ltd. and Tata ...

Commenting on the launch, Achin Gupta, Global Chief Operating Officer, Cipla Limited, said, "The launch of Yurpeak marks a transformative moment in the fight against obesity and type 2diabetes ...

Yurpeak is the second tirzepatide brand from Eli Lilly to be launched in the country after receiving approval from the drug regulator.

Cipla Limited has launched Yurpeak, a once-weekly injectable therapy for obesity and type 2 diabetes management in India.